These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15835525)

  • 1. [Drug committees should be abolished because the reality has changed].
    Jönsson B; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Mar 14-20; 102(11):880-1; discussion 882-3. PubMed ID: 15835525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Choice of drugs--by whom, for whom and to what costs?].
    Frisk M; Strömstedt A
    Lakartidningen; 2000 Sep; 97(39):4343-6. PubMed ID: 11076479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug committees in Denmark. Status and future challenges].
    Rabøl R; Kampmann JP; Christensen HR
    Ugeskr Laeger; 2004 Aug; 166(35):2988-91. PubMed ID: 15387009
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].
    Garpenby P
    Lakartidningen; 2004 Aug; 101(32-33):2480-2, 2484. PubMed ID: 15346621
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug utilization decisions should be based on cost-benefit data].
    Bengt J; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
    [No Abstract]   [Full Text] [Related]  

  • 6. [Health economic evaluation of recommended drug treatment].
    Jendteg S; Persson U; Anell A
    Lakartidningen; 2002 Jul; 99(30-31):3130-1. PubMed ID: 12198934
    [No Abstract]   [Full Text] [Related]  

  • 7. [Feedback on prescribing profiles at a primary health center. Important element in quality assurance of drug prescription].
    Nyman K; Bergens A; Björin AS; Guterstam P; Nyrén O; Jansson U; Wettermark B; Bergman U
    Lakartidningen; 2001 Jan; 98(3):160-4. PubMed ID: 11271576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality reports reduce drug costs in primary health care. Stockholm County Council a model for decentralized expenditure responsibility].
    Almkvist H; Bergman U; Edlert M; Juhasz-Haverinen M; Pehrsson A; Bergen-Dahl GT; Veg A; Wettermark B
    Lakartidningen; 2008 Oct 15-21; 105(42):2930-4. PubMed ID: 19025150
    [No Abstract]   [Full Text] [Related]  

  • 9. Rational drug use (II): Hospital drug and therapeutics committees.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Sep; 46(9):256-9. PubMed ID: 11320773
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug committees are not necessary--therapeutic recommendations are issued anyway].
    Jönsson B
    Lakartidningen; 2005 Jul 11-24; 102(28-29):2085-6: discussion 290-2. PubMed ID: 16097181
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rational drug prescription: a question of knowledge and direction. Qualitative study at ten community health centers in the county of Stockholm].
    Jägestedt M; Ronge S; Wettermark B; Karlsson EA
    Lakartidningen; 2008 Oct 15-21; 105(42):2924-9. PubMed ID: 19025149
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reply 1: LAKSAK supports wise drug therapy using knowledge and sharp IT-tools].
    Gustafsson LL; Hensjö LO
    Lakartidningen; 2000 Sep; 97(39):4347. PubMed ID: 11076480
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational drug use. Part I: The role of national drug policies.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Aug; 46(8):229-32. PubMed ID: 11317597
    [No Abstract]   [Full Text] [Related]  

  • 14. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
    Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lists presented by eight drug committees compared. The number of preparations varies. Similar views on the most expensive drugs].
    Bergman U; Myrhed M
    Lakartidningen; 1996 Apr; 93(15):1459-60. PubMed ID: 8667738
    [No Abstract]   [Full Text] [Related]  

  • 16. [The DU90% is a new quality measure for drug prescription. Non-steroidal anti-inflammatory agents as an example for analysis].
    Bergman U; Wettermark B; Myrhed M; Arrhenius L
    Lakartidningen; 1998 Sep; 95(39):4237-8, 4241-2. PubMed ID: 9785772
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is it correct to receive a bonus in connection with drug prescription?].
    Olsson S
    Lakartidningen; 2002 May; 99(20):2331; author reply 2331. PubMed ID: 12082958
    [No Abstract]   [Full Text] [Related]  

  • 18. The 'wise list'- a comprehensive model for drug and therapeutics committees to achieve adherence to recommendations for essential drugs among prescribers?
    Stichele RV
    Basic Clin Pharmacol Toxicol; 2011 Apr; 108(4):221-3. PubMed ID: 21414142
    [No Abstract]   [Full Text] [Related]  

  • 19. [The responsibility for medications list should be clear. Swedish Drug Committees (LOK) has published guidelines].
    Rahmner PB; Lundborg M
    Lakartidningen; 2011 Jun 1-14; 108(22-23):1250-2. PubMed ID: 21786501
    [No Abstract]   [Full Text] [Related]  

  • 20. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A
    Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.